Sodium‐Glucose Cotransporter‐2 Inhibitor Prevents Stroke in Patients With Diabetes and Atrial Fibrillation

Background Atrial fibrillation (AF) is associated with increasing risk of thromboembolic or ischemic stroke. The CHA2DS2‐VASc score is a well‐established predictor of AF stroke. Patients with AF have an increased risk of stroke if they have diabetes. Use of sodium‐glucose cotransporter‐2 inhibitor (...

Full description

Bibliographic Details
Main Authors: Sheng‐Nan Chang, Jien‐Jiun Chen, Pang‐Shuo Huang, Cho‐Kai Wu, Yi‐Chih Wang, Juey‐Jen Hwang, Chia‐Ti Tsai
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.027764